244 related articles for article (PubMed ID: 35330560)
21. Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome.
Luo Y; Ge S; Chen Q; Lin S; He W; Zeng M
Stem Cell Res Ther; 2023 Feb; 14(1):27. PubMed ID: 36788588
[TBL] [Abstract][Full Text] [Related]
22. [Effects of Hippo signaling pathway on lung injury repair by mesenchymal stem cells in acute respiratory distress syndrome].
Li L; Dong L; Gao F; Hui J; Chen Y; Yan J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):281-287. PubMed ID: 30914086
[TBL] [Abstract][Full Text] [Related]
23. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
[TBL] [Abstract][Full Text] [Related]
24. Lung-Resident Mesenchymal Stem Cells Promote Repair of LPS-Induced Acute Lung Injury via Regulating the Balance of Regulatory T cells and Th17 cells.
Wang L; Shi M; Tong L; Wang J; Ji S; Bi J; Chen C; Jiang J; Bai C; Zhou J; Song Y
Inflammation; 2019 Feb; 42(1):199-210. PubMed ID: 30187337
[TBL] [Abstract][Full Text] [Related]
25. Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment.
Liu C; Xiao K; Xie L
Front Immunol; 2022; 13():928134. PubMed ID: 35880175
[TBL] [Abstract][Full Text] [Related]
26. Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats.
Chou HC; Chang CH; Chen CH; Lin W; Chen CM
Stem Cell Res Ther; 2021 May; 12(1):258. PubMed ID: 33933128
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L
Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626
[TBL] [Abstract][Full Text] [Related]
28. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
[TBL] [Abstract][Full Text] [Related]
29. Human Umbilical Cord Mesenchymal Stem Cells Improve Lung Function in Chronic Obstructive Pulmonary Disease Rat Model Through Regulating Lung Microbiota.
Zhang X; Hu T; Yu X; Wang T; Jiang L; Sun L; Han W
Stem Cells; 2024 Apr; 42(4):346-359. PubMed ID: 38279981
[TBL] [Abstract][Full Text] [Related]
30. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
31. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
[TBL] [Abstract][Full Text] [Related]
32. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Attenuate LPS-Induced ARDS by Modulating Macrophage Polarization Through Inhibiting Glycolysis in Macrophages.
Deng H; Wu L; Liu M; Zhu L; Chen Y; Zhou H; Shi X; Wei J; Zheng L; Hu X; Wang M; He Z; Lv X; Yang H
Shock; 2020 Dec; 54(6):828-843. PubMed ID: 32433208
[TBL] [Abstract][Full Text] [Related]
33. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.
Monsel A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Nguekap Tchoumba O; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Malard-Castagnet S; Burrel S; Rosenzwajg M; Tchitchek N; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Ropers J; Menasché P; Larghero J;
Crit Care; 2022 Feb; 26(1):48. PubMed ID: 35189925
[TBL] [Abstract][Full Text] [Related]
34. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
35. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.
Zheng G; Huang L; Tong H; Shu Q; Hu Y; Ge M; Deng K; Zhang L; Zou B; Cheng B; Xu J
Respir Res; 2014 Apr; 15(1):39. PubMed ID: 24708472
[TBL] [Abstract][Full Text] [Related]
37. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Ganjali R; Tafreshian AR; Tavakol-Afshari J
Stem Cell Res Ther; 2022 Jun; 13(1):283. PubMed ID: 35765103
[TBL] [Abstract][Full Text] [Related]
39. Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model.
Valiukevičius P; Mačiulaitis J; Pangonytė D; Siratavičiūtė V; Kluszczyńska K; Kuzaitytė U; Insodaitė R; Čiapienė I; Grigalevičiūtė R; Zigmantaitė V; Vitkauskienė A; Mačiulaitis R
Cells; 2023 Nov; 12(23):. PubMed ID: 38067158
[TBL] [Abstract][Full Text] [Related]
40. Umbilical cord MSC-derived exosomes improve alveolar macrophage function and reduce LPS-induced acute lung injury.
Cui E; Lv L; Wang B; Li L; Lu H; Hua F; Chen W; Chen N; Yang L; Pan R
J Cell Biochem; 2024 Feb; 125(2):e30519. PubMed ID: 38224137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
